Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • July 26 2023

    Client Alert: Department of Homeland Security Announces Updated Form I-9 and Remote Verification Procedure

    On July 21, 2023, the U.S. Department of Homeland Security (“DHS”) announced an updated Form I-9 and remote I-9 verification procedure (referred to by DHS as “the Alternative Procedure”). Employers will be required to use the updated Form I-9 starting November 1, 2023. Separately, employers who were unable to review employees’ Form I-9 documents in person during the COVID-19 pandemic will be required to examine those documents in person, or through the Alternative Procedure, by August 30, 2023.

    Click here to read the alert.

  • July 25 2023

    Contango ORE, Inc., a company that engages in exploration for gold and associated minerals in Alaska, announced the pricing of its previously announced underwritten public offering in the amount of $30,400,000. EGS acted as counsel to Maxim Group LLC, one of the joint book-runners for the Offering.

  • July 25 2023

    Nico Ciliotta, an Associate of the Firm, wrote an article for Total Food Service titled: “Be Wary of Disciplining Employees for Using Legally Protected Absences – Stiff Fines or Costly Lawsuits Could Follow.”

    Click here to read the article.

  • July 25 2023

    Asensus Surgical, Inc. announced the closing of its Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.

  • July 23 2023

    Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.

  • July 23 2023

    PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.

  • July 22 2023

    PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.

  • July 22 2023

    First Wave BioPharma, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”